{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:27:11Z","timestamp":1785432431459,"version":"3.56.0"},"reference-count":25,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004361","name":"Swiss Cancer League","doi-asserted-by":"publisher","award":["KFS-5613-08-2022"],"award-info":[{"award-number":["KFS-5613-08-2022"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"award":["KFS-5613-08-2022"],"award-info":[{"award-number":["KFS-5613-08-2022"]}],"id":[{"id":"https:\/\/ror.org\/01pd7my79","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: The heterogenous nature of renal cell carcinomas (RCCs) is increasingly recognized. The purpose of this proof-of-concept pilot study was to evaluate correlations between multiparametric MRI (mpMRI)-derived and histopathological parameters in RCCs from spatially matched regions on both MRI and pathological examination to support targeted biopsy planning. Methods: In this prospective single-center pilot study, patients with solid renal tumors \u22652 cm undergoing nephrectomy were prospectively enrolled. Each patient underwent preoperative 3.0T-mpMRI including T2-weighted and pre-\/post-contrast T1-weighted sequences, chemical-shift imaging, IVIM-DWI, and T1\/T2*\/R2 mapping. Tumor regions were defined jointly by a pathologist and radiologist, and identical regions of interest were assessed for each tumor region across all sequences to gain quantitative mpMRI-derived parameters. Histopathology provided quantitative regional fractions of viable tumor, fibrosis, hemorrhage, and cystic\/necrotic components. Spearman\u2019s rank correlations and univariable linear regression assessed associations between mpMRI and histopathological parameters on a regional level. Results: Across 49 tumor regions in eight patients (65.3% clear cell, 34.7% papillary RCCs), the mean viable tumor fraction was 80.9% (SD 17.6). The viable tumor fraction showed inverse correlations with nephrographic and delayed phase signal intensity changes (rho = \u22120.59\/rho = \u22120.51), T1 values (rho = \u22120.56), true diffusion coefficient D (rho = \u22120.47), and ADC (rho = \u22120.45), and a positive correlation with R2 times (rho = 0.55). Delayed and nephrographic phase signal intensity changes (R2 = 0.41\/R2 = 0.39) were the strongest single exploratory imaging correlates of viable tumor fraction. Conclusions: These findings support the feasibility of quantitative mpMRI parameters to capture regional intratumoral heterogeneity in RCCs, thereby highlighting regions with high viable tumor burden, which may help to refine the imaging-based assessment of RCCs in the future.<\/jats:p>","DOI":"10.3390\/diagnostics16132119","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:04:49Z","timestamp":1783411489000},"page":"2119","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor Heterogeneity of RCCs Assessed by mpMRI with Direct Radiological\u2013Histopathological Correlation"],"prefix":"10.3390","volume":"16","author":[{"given":"Antonia M.","family":"Pausch","sequence":"first","affiliation":[{"name":"Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8335-8731","authenticated-orcid":false,"given":"Viktoria S.","family":"Hadnagy","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7505-4299","authenticated-orcid":false,"given":"Toni","family":"Rabadi","sequence":"additional","affiliation":[{"name":"Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8866-8010","authenticated-orcid":false,"given":"Daniel","family":"Eberli","sequence":"additional","affiliation":[{"name":"Department of Urology, University Hospital Zurich, 8008 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels J.","family":"Rupp","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"H\u00f6tker","sequence":"additional","affiliation":[{"name":"Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part A: Renal, Penile, and Testicular Tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/OP.21.00419","article-title":"Clinical Review on the Management of Metastatic Renal Cell Carcinoma","volume":"18","author":"Tran","year":"2022","journal-title":"JCO Oncol. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"Renal Cell Carcinoma: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up","volume":"35","author":"Powles","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New Developments in Existing WHO Entities and Evolving Molecular Concepts: The Genitourinary Pathology Society (GUPS) Update on Renal Neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.juro.2015.11.029","article-title":"Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature","volume":"195","author":"Patel","year":"2016","journal-title":"J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2015.07.072","article-title":"Systematic Review and Meta-Analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy","volume":"69","author":"Marconi","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Garnier, C., Ferrer, L., Vargas, J., Gallinato, O., Jambon, E., Le Bras, Y., Bernhard, J.-C., Colin, T., Grenier, N., and Marcelin, C. (2023). A CT-Based Clinical, Radiological and Radiomic Machine Learning Model for Predicting Malignancy of Solid Renal Tumors (UroCCR-75). Diagnostics, 13.","DOI":"10.3390\/diagnostics13152548"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"W85","DOI":"10.2214\/AJR.16.16652","article-title":"Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach","volume":"208","author":"Mazaheri","year":"2017","journal-title":"Am. J. Roentgenol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111741","DOI":"10.1016\/j.ejrad.2024.111741","article-title":"MRI Quantitative T1 and T2 Mapping of the Renal Cortex: Assessment of Normal Values and Potential Usefulness for Renal Masses at 3 T","volume":"181","author":"Henry","year":"2024","journal-title":"Eur. J. Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Woon, D., Qin, S., Al-Khanaty, A., Perera, M., and Lawrentschuk, N. (2024). Imaging in Renal Cell Carcinoma Detection. Diagnostics, 14.","DOI":"10.3390\/diagnostics14182105"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jmri.23899","article-title":"Multiphasic Contrast-Enhanced MRI: Single-Slice versus Volumetric Quantification of Tumor Enhancement for the Assessment of Renal Clear-Cell Carcinoma Fuhrman Grade","volume":"37","author":"Vargas","year":"2013","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00292-016-0171-y","article-title":"WHO-ISUP-Graduierungssystem f\u00fcr Nierenkarzinome","volume":"37","author":"Moch","year":"2016","journal-title":"Pathologe"},{"key":"ref_14","unstructured":"R Core Team (2025). R: A Language and Environment for Statistical Computing, R Core Team."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mrm.22740","article-title":"Intravoxel Incoherent Motion (IVIM) Imaging of Tumor Microenvironment in Locally Advanced Breast Cancer","volume":"65","author":"Sigmund","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1007\/s00330-018-5331-4","article-title":"Late Gadolinium Enhancement of Colorectal Liver Metastases Post-Chemotherapy Is Associated with Tumour Fibrosis and Overall Survival Post-Hepatectomy","volume":"28","author":"Cheung","year":"2018","journal-title":"Eur. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2214\/AJR.19.21093","article-title":"Update on Indications for Percutaneous Renal Mass Biopsy in the Era of Advanced CT and MRI","volume":"212","author":"Lim","year":"2019","journal-title":"Am. J. Roentgenol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1007\/s00330-020-06666-3","article-title":"Radiomics of Computed Tomography and Magnetic Resonance Imaging in Renal Cell Carcinoma\u2014A Systematic Review and Meta-Analysis","volume":"30","author":"Ursprung","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/RLI.0000000000001087","article-title":"A Prospective Study of the Diagnostic Performance of Photon-Counting CT Compared With MRI in the Characterization of Renal Masses","volume":"59","author":"Homayounieh","year":"2024","journal-title":"Investig. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100608","DOI":"10.1016\/j.ejro.2024.100608","article-title":"MRI-Based Radiomics Machine Learning Model to Differentiate Non-Clear Cell Renal Cell Carcinoma from Benign Renal Tumors","volume":"13","author":"Wang","year":"2024","journal-title":"Eur. J. Radiol. Open"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1158\/1078-0432.CCR-21-0706","article-title":"Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform","volume":"27","author":"Udayakumar","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5114\/pjr.2020.101476","article-title":"Intravoxel Incoherent Motion Magnetic Resonance Imaging: Basic Principles and Clinical Applications","volume":"85","author":"Pasicz","year":"2020","journal-title":"Pol. J. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/j.clgc.2016.04.007","article-title":"Intratumor Heterogeneity of Perfusion and Diffusion in Clear Cell Renal Cell Carcinoma: Correlation with Tumor Cellularity","volume":"14","author":"Yuan","year":"2016","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MOU.0000000000000516","article-title":"The Genomics of Renal Cell Carcinoma and Its Role in Renal Mass Biopsy","volume":"28","author":"Salami","year":"2018","journal-title":"Curr. Opin. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15586\/jkcvhl.2020.134","article-title":"Histologic Heterogeneity of Extirpated Renal Cell Carcinoma Specimens: Implications for Renal Mass Biopsy","volume":"7","author":"Nahouraii","year":"2020","journal-title":"J. Kidney Cancer VHL"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:55:18Z","timestamp":1783414518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":25,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16132119"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16132119","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}